Nefense, a company specializing in advanced clinical hygiene and airway health solutions, has announced the launch of its Hypochlorous Acid (HOCl) nasal spray line. The product family includes Hyponasal, Hyponasal Junior, and Hypobaby, targeting adults, children, and infants respectively. These sprays aim to provide safe, effective nasal care without medications or steroids.
The flagship product, Hyponasal HOCl Nose Spray, is designed for daily nasal hygiene. It uses HOCl, a molecule naturally produced by the human immune system, to flush away environmental irritants and support respiratory defenses. According to Dr. Richard D. Downs, D.D.S., "Proper airway management begins with maintaining a clean and healthy nasal cavity. With Hyponasal, we are providing a superior biocleanse solution that addresses daily irritation at its source."
The science behind HOCl highlights its anti-microbial and anti-inflammatory properties, making it suitable for natural nasal care. Dr. Joseph Zelk, a sleep specialist, noted, "The anti-inflammatory and antimicrobial properties of HOCl make it a remarkable tool for naturally clearing the airway, mitigating allergies, and supporting healthier breathing."
For children and infants, Hyponasal Jr. and Hypobaby offer pediatric formulations tailored for sensitive nasal passages. Dr. Shane Smith emphasized, "Hypobaby and Hyponasal Jr. offer unparalleled peace of mind, delivering a clinical-grade cleanse that is potent enough for little noses while remaining highly effective."
Consumer interest in respiratory wellness is growing, with many seeking drug-free approaches to nasal hygiene and allergy management. This product line addresses those needs, supporting healthy breathing habits and sleep-supportive practices. Nefense's portfolio also includes XyloClean, a xylitol-based nasal spray. For more information, visit Nefense.com.
